Neuroethial Debate in Cognitive Enhancement

593 Words Jan 31st, 2018 2 Pages
Neurocognitive enhancers (e.g. nootropics, stimulants) are psychoactive medications that aim to extend the abilities of the human mind. Although these drugs are being developed for the primary purpose of treating neurological conditions like dementia, some of the medications also improve performance in the healthy (Chaterjee 2). Pharmaceuticals that are used in the context of satisfying a non-medical goal are regarded as lifestyle drugs (Flower 182). Lifestyle medicine treats issues that rest at the margins of health and well-being. Whether we like it or not, there is a growing demand for cognitive enhancement. Barbara Sahakian, clinical neuropsychologist at Cambridge University, tells The New Yorker that “the drive for self-enhancement of cognition is likely to be as strong if not stronger than in the realms of ‘enhancement’ of beauty and sexual function” (Talbot). Our growing understanding of the neural bases of behavior, personality, and cognition will only catalyze the intense research efforts to develop neuroenhancers. The neuroscientific advances in our consumerist society make cosmetic neurology near inevitable. Thus, cosmetic psychopharmacology should not be prohibited.

The Stanford Encylopedia of Philosophy defines morality as…
Open Document